Resources

Mirthful laughter was linked to lower cholesterol and less risk of cardiovascular disease in a study of high-risk diabetic patients, U.S. researchers said. The addition of an adjunct therapeutic mirthful laughter Rx (a potential modulator of positive mood state) to standard diabetes care may lower stress and inflammatory response and …

Researchers have uncovered new evidence suggesting factors other than genes could cause obesity, finding that genetically identical cells store widely differing amounts of fat depending on subtle variations in how cells process insulin.

Exercising after short-term fasting (such as before breakfast) may increase the amount of fat burned.

Scientists at Burnham Institute for Medical Research have demonstrated in mice that transplanted pancreatic precursor cells are protected from the immune system when encapsulated in polytetrafluorethylene (PTFE).

A child’s inability to delay gratification at age 4 predicted an increased likelihood of being overweight at age 11, data from an NIH-sponsored study showed.

Metformin may have long-term benefits in patients with Type 2 diabetes mellitus (DM2), according to the results of a randomized, placebo-controlled trial. Add-on metformin improved glycemic control and reduced body weight and insulin requirements.

The majority of patients with Type 1 diabetes who underwent a certain type of stem cell transplantation became insulin free, several for more than three years, with good glycemic control, and also increased C-peptide levels, an indirect measure of beta-cell function, according to a new study.

Individuals who reduced added sugar intake by the equivalent of 1 can of soda per day or increased fiber intake by the equivalent of a cup of beans showed improvements in key risk factors for Type 2 diabetes, specifically in insulin secretion and visceral fat.

A striking new study says almost one in five American 4-year-olds is obese, and the rate is alarmingly higher among American Indian children, with nearly one-third of them obese.

In diabetic men treated with statins, particularly atorvastatin, evaluating androgen status using total testosterone may cause diagnostic error, according to the results of a cross-sectional study.